U.S. Auto Stock News

Travere Therapeutics (TVTX) just secured full FDA approval for FILSPARI in focal segmental glomerulosclerosis without nephrotic syndrome, extending its use beyond IgA nephropathy and reshaping how investors may think about the company’s rare kidney portfolio. See our latest analysis for Travere Therapeutics. The FDA decision arrives alongside a sharp 46.95% 1 month share price return and a 37.57% 3 month share price return, while the 1 year total shareholder return of 120.95% points to strong...

Edgewise Therapeutics (EWTX) has drawn investor attention after recent trading left the stock around $31.58, with returns showing mixed short term moves but a strong year to date and 1 year profile. See our latest analysis for Edgewise Therapeutics. Recent trading has been choppy, with a 1 day share price return of 1.12% and a 7 day share price return of an 8.28% decline. However, momentum over the past 90 days and year to date remains positive, supported by a 1 year total shareholder return...

Atomera Incorporated recently announced it has expanded its long-running collaboration with Synopsys to develop gallium nitride (GaN) device modeling workflows for radio frequency and power semiconductor applications using Synopsys’ Sentaurus TCAD and Atomera’s MSTcad toolset. This move extends Atomera’s MST modeling capabilities into GaN, potentially deepening its role in high-value RF and power markets by integrating more tightly into Synopsys’ widely used design ecosystem. We’ll now...

Evolv Technologies Holdings, Inc. recently announced multi-year subscription agreements and marketing partnerships with the University of Washington’s athletic department and Crypto.com Arena, expanding deployments of its Evolv Express Gen2 and eXpedite AI-based screening systems across major college and professional sports venues. These high-traffic stadium and arena wins highlight growing adoption of Evolv’s subscription-based security platforms in sports and entertainment, reinforcing its...

The American Academy of Dermatology’s new pediatric guidelines give a strong, evidence-backed endorsement to Arcutis Biotherapeutics (ARQT) lead product ZORYVE for children with mild to moderate atopic dermatitis, highlighting efficacy, safety, and long-term use. See our latest analysis for Arcutis Biotherapeutics. At a share price of $23.26, Arcutis has a 1 day share price return of 1.75%, while the year to date share price return of 19.79% decline contrasts with a 1 year total shareholder...

Event context and recent share performance Innospec (IOSP) shares recently closed at US$77.15, with the stock showing a return of about 0.6% over the past day and 1.3% over the past week. This sets the context for its latest trading moves. See our latest analysis for Innospec. Recent trading has been mixed, with a 6.6% 1 month share price return contrasting with a 4.6% 3 month share price decline and a 12.2% 1 year total shareholder return loss. This suggests momentum has cooled after a short...

Recent performance and context for W.W. Grainger W.W. Grainger (GWW) has drawn fresh investor attention after recent share price moves, with the stock showing mixed short term returns but positive performance over the month and the past 3 months. See our latest analysis for W.W. Grainger. Recent trading has been slightly softer, with a 1-day share price return of 1.45% and a 7-day share price return of 1.29%. That sits against a 30-day share price return of 6.7% and a 1-year total shareholder...

Some investors may be wondering whether Broadcom's share price still reflects good value after a strong run, or if expectations are getting ahead of themselves. Broadcom's stock has returned 4.0% over the past week, 32.6% over the last 30 days, 21.6% year to date, 121.6% over the past year and a very large return over 5 years. These moves have kept Broadcom in the spotlight, as investors weigh what the current price indicates about future prospects and risk. Recent coverage has focused on...

Recent performance snapshot for Microsoft (MSFT) With no single headline event driving attention today, Microsoft (MSFT) is drawing interest as investors reassess its recent share performance, business mix, and current valuation signals across its major cloud, productivity, and personal computing segments. See our latest analysis for Microsoft. At a latest share price of $424.62, Microsoft has recently seen a 16.0% 1 month share price return. Its 90 day share price return of 8.9% and year to...

Oracle (NYSE:ORCL) has secured US$16b in financing for a large AI data center campus in Michigan. The project involves Related Digital and Blackstone as key development and financing partners. The campus is designed to support Oracle's dedicated AI infrastructure for OpenAI and other customers in the US. Oracle is best known for its database software, cloud infrastructure and enterprise applications, and this Michigan campus fits into its push to supply compute for AI workloads. Across the...

Q1 2026 results set the stage for a margin story at Marten Transport (MRTN) Marten Transport (MRTN) has opened 2026 with Q1 revenue of US$203.5 million, basic EPS of US$0.02 and net income of US$1.4 million, while the latest trailing twelve month figures stand at US$864.0 million of revenue and basic EPS of US$0.19. Over recent quarters the company has seen revenue shift from US$223.2 million in Q1 2025 to US$203.5 million in Q1 2026, with quarterly EPS moving from US$0.05 to US$0.02...

Recent share performance and business snapshot Lucky Strike Entertainment (LUCK) has drawn attention after a recent pullback, with the share price closing at US$7.24 as investors reassess the business following its rebrand from Bowlero Corp. The company runs a portfolio of bowling centers and entertainment venues across North America, including AMF, Bowl America, Lucky Strike, Bowlero, Octane Raceway, several water parks, and Boomers Parks. It has reported revenue of US$1,240.203 million and...

Lucid Group (LCID) is back in focus after a packed April 14, when the company named Silvio Napoli as its next CEO, expanded its Uber partnership, and raised fresh equity and preferred capital. See our latest analysis for Lucid Group. Despite the fresh CEO appointment, the deeper Uber tie up and new funding, Lucid’s 30 day share price return of 41.48% and 1 year total shareholder return of 75% signal that recent momentum has been weak and longer term holders have taken heavy losses. If you are...

Why EZCORP (EZPW) Has Been Drawing Investor Attention EZCORP (EZPW) has been attracting attention after a strong share price move over the past month and past 3 months, prompting investors to reassess the pawn-focused lender’s fundamentals and recent performance. See our latest analysis for EZCORP. The recent share price momentum looks strong, with a 24.45% 1 month share price return and 50.78% 3 month share price return feeding into a 58.82% year to date share price return and a very large 5...

Alphabet plans to invest up to $40b in Anthropic, including an initial $10b and up to $30b tied to performance milestones. The agreement significantly expands Anthropic's access to Google Cloud computing capacity, with up to 5 gigawatts over five years. The deal deepens Alphabet's role as both a core infrastructure provider and key financial backer for Anthropic. Alphabet, traded as NasdaqGS:GOOGL, is entering this expanded AI partnership with Anthropic at a time when its shares trade...

Super Group (SGHC) Limited recently reported past full-year 2025 results, with sales rising to US$2.23 billion and net income reaching US$217 million, alongside higher basic and diluted earnings per share from continuing operations. At the same time, Super Group’s new role as Formula 1’s first Official Betting Operator and upbeat analyst earnings expectations highlight how product innovation and external confidence are shaping its growth story. Next, we’ll examine how Super Group’s strong...

For readers wondering whether International Flavors & Fragrances is attractively priced right now or if the recent share moves are already baking in the story, this article walks through the numbers so you can judge the value for yourself. The stock closed at US$71.14, with a recent 7-day return of a 6.2% decline, a 30-day return of 0.6%, a year-to-date return of 4.6%, and a 1-year return of a 4.4% decline that sits against a 3-year return of a 20.6% decline and a 5-year return of a 42.8%...

SkyWest (SKYW) has kicked off Q1 2026 with total revenue of US$1.0b, basic EPS of US$2.54 and net income of US$101.7 million, setting the tone for its latest set of results. The company has seen quarterly revenue move from US$948.5 million in Q1 2025 to US$1.0b in Q1 2026, while basic EPS has shifted from US$2.48 to US$2.54 over the same period, against a backdrop of trailing 12 month EPS of US$10.69 and net income of US$429.5 million. With a trailing net margin of 10.4% versus 9.9% the prior...

Wondering if Atlas Energy Solutions at around US$16.31 offers good value for your money? This article focuses on what the current share price might mean for long-term investors. The stock has shown sharp recent moves, with returns of 22.7% over 7 days, 20.3% over 30 days, 67.8% year to date and 19.1% over the past year. These figures can change how you think about both potential upside and risk. Recent coverage has centered on Atlas Energy Solutions as investors reassess US energy services...

Why the New York lawsuit decision matters for DLocal (NasdaqGS:DLO) investors The latest move in DLocal (NasdaqGS:DLO) stock comes after the New York Appellate Division unanimously upheld the dismissal of a securities class action challenging disclosures in the company’s registration statement and prospectus. The court agreed that all claims against DLocal and its executives lacked merit, rejecting allegations around supposed trends in the company’s take rate. The decision also referred to...

Why Caris Life Sciences Is On Investors’ Radar Caris Life Sciences (CAI) has attracted fresh attention after recent share price moves, with the stock up about 10% over the past month but showing a roughly 19% decline over the past 3 months. See our latest analysis for Caris Life Sciences. The recent 10.2% 30 day share price return stands against a 19.2% 90 day decline and a 25.1% year to date share price fall, indicating fading momentum despite the latest move. If Caris’s recent swings have...

A new product liability lawsuit alleges a design flaw in Newell Brands' CrockPot Express Crock Multicooker led to severe burn injuries when the lid opened while still under pressure. The case targets Newell Brands, listed as NasdaqGS:NWL, and focuses on product safety controls and consumer protection around its popular small appliance line. Newell Brands, through its CrockPot range, is a familiar name in many kitchens, so any allegation around product safety can quickly draw attention from...

Why Callaway Golf (CALY) Is Back in Focus Callaway Golf (CALY) is on investors’ radar after a recent name change from Topgolf Callaway Brands Corp. This shift has refocused attention on its core golf equipment and apparel business and how that mix supports current valuation. See our latest analysis for Callaway Golf. The share price at US$15.31 reflects a strong year to date share price return of 30.63%, while the 128.17% total shareholder return over one year contrasts with weaker three and...

In the first quarter of 2026, Boeing reported revenue of US$22,217 million versus US$19,496 million a year earlier, with its net loss narrowing to US$4 million and loss per share from continuing operations improving to US$0.11. Alongside this earnings improvement, Boeing’s record US$695.00 billion order backlog and higher commercial jet deliveries highlight substantial embedded demand across both its commercial and defense businesses. With this backdrop of stronger-than-expected Q1 results,...